ID

31555

Descripción

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00559481

Link

https://clinicaltrials.gov/show/NCT00559481

Palabras clave

Versiones (1)
  1. 3/9/18 3/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

3 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00559481

Inglés

Eligibility Prostate Cancer NCT00559481

1 formularios  
Criteria
Descripción

Criteria

confirmed diagnosis of prostate cancer
Descripción

Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
must have failed standard androgen-deprivation therapy
Descripción

Antiandrogen therapy failed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0231175
evidence of rising psa
Descripción

Raised prostate specific antigen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0178415
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
ecog performance status 0-2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
creatinine ≤ 2.0 mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
ast and alt < 4 times upper limit of normal
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
bilirubin < 2.0 mg/dl
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
no active congestive heart failure
Descripción

Exclusion | Congestive heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0018802
no allergy to ketoconazole, dexamethasone, hydrocortisone, or to one of the components of dexamethasone, hydrocortisone, or ketoconazole
Descripción

Exclusion Criteria | Ketoconazole allergy | Dexamethasone allergy | Hydrocortisone allergy | Hypersensitivity Dexamethasone Component | Hypersensitivity Hydrocortisone Component | Hypersensitivity Ketoconazole Component

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0571275
UMLS CUI [3]
C0571611
UMLS CUI [4]
C0571588
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0011777
UMLS CUI [5,3]
C1705248
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0020268
UMLS CUI [6,3]
C1705248
UMLS CUI [7,1]
C0020517
UMLS CUI [7,2]
C0022625
UMLS CUI [7,3]
C1705248
no active infection
Descripción

Exclusion | Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0009450
no uncontrolled glaucoma
Descripción

Exclusion | Glaucoma Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0017601
UMLS CUI [2,2]
C0205318
no active peptic ulcer disease
Descripción

Exclusion | Peptic Ulcer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0030920
no uncontrolled diabetes mellitus
Descripción

Exclusion | Diabetic - poor control

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2]
C0421258
fertile patients must use effective contraception during and for 3 months after completion of study therapy
Descripción

Fertility Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
more than 2 weeks since prior and no concurrent drugs known to interact with study treatment
Descripción

Exclusion | Pharmaceutical Preparations Interaction Investigational Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0687133
UMLS CUI [2,3]
C0949266
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00559481

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Prostate carcinoma
Item
confirmed diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
Antiandrogen therapy failed
Item
must have failed standard androgen-deprivation therapy
boolean
C0279492 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
Raised prostate specific antigen
Item
evidence of rising psa
boolean
C0178415 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine ≤ 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast and alt < 4 times upper limit of normal
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Serum total bilirubin measurement
Item
bilirubin < 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
Exclusion | Congestive heart failure
Item
no active congestive heart failure
boolean
C2828389 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
Exclusion Criteria | Ketoconazole allergy | Dexamethasone allergy | Hydrocortisone allergy | Hypersensitivity Dexamethasone Component | Hypersensitivity Hydrocortisone Component | Hypersensitivity Ketoconazole Component
Item
no allergy to ketoconazole, dexamethasone, hydrocortisone, or to one of the components of dexamethasone, hydrocortisone, or ketoconazole
boolean
C0680251 (UMLS CUI [1])
C0571275 (UMLS CUI [2])
C0571611 (UMLS CUI [3])
C0571588 (UMLS CUI [4])
C0020517 (UMLS CUI [5,1])
C0011777 (UMLS CUI [5,2])
C1705248 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0020268 (UMLS CUI [6,2])
C1705248 (UMLS CUI [6,3])
C0020517 (UMLS CUI [7,1])
C0022625 (UMLS CUI [7,2])
C1705248 (UMLS CUI [7,3])
Exclusion | Communicable Disease
Item
no active infection
boolean
C2828389 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
Exclusion | Glaucoma Uncontrolled
Item
no uncontrolled glaucoma
boolean
C2828389 (UMLS CUI [1])
C0017601 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Exclusion | Peptic Ulcer
Item
no active peptic ulcer disease
boolean
C2828389 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
Exclusion | Diabetic - poor control
Item
no uncontrolled diabetes mellitus
boolean
C2828389 (UMLS CUI [1])
C0421258 (UMLS CUI [2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during and for 3 months after completion of study therapy
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion | Pharmaceutical Preparations Interaction Investigational Therapy
Item
more than 2 weeks since prior and no concurrent drugs known to interact with study treatment
boolean
C2828389 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0687133 (UMLS CUI [2,2])
C0949266 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial